These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17028251)

  • 1. Low-dose dexamethasone test with "inverse" results: a possible new pattern of cortisol response.
    Mueller C; Sieber-Ruckstuhl N; Wenger M; Kaser-Hotz B; Reusch CE
    Vet Rec; 2006 Oct; 159(15):489-91. PubMed ID: 17028251
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinguishing dogs with functioning adrenocortical tumors from dogs with pituitary-dependent hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1983 Jul; 183(2):195-200. PubMed ID: 6309721
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1996 Aug; 209(4):772-5. PubMed ID: 8756877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia.
    Norman EJ; Thompson H; Mooney CT
    Vet Rec; 1999 May; 144(20):551-4. PubMed ID: 10371012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic contribution of individual components of adrenal function tests to diagnose canine hyperadrenocorticism.
    Jaffey JA; Hess RS; Webster CR; Blois SL; Hostnik ET; Heilmann RM; Jacobs C; Steiner JM; Reusch CE; Rogers E; Royal A; Piech T; Musella C; Carvalho L; Fink MJ; Motta GE; Kilkucki SN; Cigarro A; Roedler FS; Seidel T; DeClue AE
    Vet J; 2020 Sep; 263():105520. PubMed ID: 32928489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma aldosterone concentrations and plasma renin activity in healthy dogs and dogs with hyperadrenocorticism.
    Javadi S; Kooistra HS; Mol JA; Boer P; Boer WH; Rijnberk A
    Vet Rec; 2003 Oct; 153(17):521-5. PubMed ID: 14620551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1985 Jul; 187(1):49-53. PubMed ID: 2991177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs.
    Kaplan AJ; Peterson ME; Kemppainen RJ
    J Am Vet Med Assoc; 1995 Aug; 207(4):445-51. PubMed ID: 7591942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
    Mack RE; Feldman EC
    J Am Vet Med Assoc; 1990 Dec; 197(12):1603-6. PubMed ID: 2177458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of canine hyperadrenocorticism, using computed tomography.
    Emms SG; Wortman JA; Johnston DE; Goldschmidt MH
    J Am Vet Med Assoc; 1986 Aug; 189(4):432-9. PubMed ID: 3019972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dental restoration under general anaesthesia on the low-dose dexamethasone suppression test in dogs.
    Hoffrogge S; Schmicke M; Mischke R
    Res Vet Sci; 2020 Apr; 129():117-119. PubMed ID: 31954882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematological changes during tetracosactrin response testing in normal dogs.
    Watson AD; Canfield PJ; Churcher RK
    Aust Vet J; 2002 Nov; 80(11):687-8. PubMed ID: 12465827
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985-1995).
    Van Liew CH; Greco DS; Salman MD
    J Am Vet Med Assoc; 1997 Aug; 211(3):322-5. PubMed ID: 9262671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of hyperadrenocorticism in dogs.
    Peterson ME
    Clin Tech Small Anim Pract; 2007 Feb; 22(1):2-11. PubMed ID: 17542191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum 17-hydroxyprogesterone concentration after administration of ACTH in dogs with hyperadrenocorticism.
    Benitah N; Feldman EC; Kass PH; Nelson RW
    J Am Vet Med Assoc; 2005 Oct; 227(7):1095-101. PubMed ID: 16220669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of sex hormones in dogs with adrenal dysfunction.
    Hill KE; Scott-Moncrieff JC; Koshko MA; Glickman LT; Glickman NW; Nelson RW; Blevins WE; Oliver JW
    J Am Vet Med Assoc; 2005 Feb; 226(4):556-61. PubMed ID: 15742696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functioning adrenocortical tumour in a dog.
    Vince ME; Watson AD
    Aust Vet J; 1982 Apr; 58(4):156-8. PubMed ID: 6289791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a six-hour combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1986 Dec; 189(12):1562-6. PubMed ID: 3025143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of individual low-dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs.
    Bennaim M; Shiel RE; Forde C; Mooney CT
    J Vet Intern Med; 2018 May; 32(3):967-977. PubMed ID: 29498108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of hyperadrenocorticism in dogs: a survey of internists and dermatologists.
    Behrend EN; Kemppainen RJ; Clark TP; Salman MD; Peterson ME
    J Am Vet Med Assoc; 2002 Jun; 220(11):1643-9. PubMed ID: 12051503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.